June 22, 2017 / 12:18 PM / a month ago

BRIEF-Trovagene reports agreement to utilize trovera® ctdna tests and services in cancer clinical trials

1 Min Read

June 22 (Reuters) - Trovagene Inc:

* Trovagene announces agreement with global biopharmaceutical company to utilize trovera® ctdna tests and services in cancer clinical trials

* Trovagene announces agreement with global biopharmaceutical company to utilize trovera® ctdna tests and services in cancer clinical trials

* Trovagene Inc - entered into an agreement with a biopharmaceutical company to provide trovera urine circulating tumor dna biomarker tests and services Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below